The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Hodgkin Lymphoma — Nodular Sclerosing Type

Most common subtype of classical Hodgkin lymphoma, often involving the mediastinum in adolescents and young adults.

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Hematoloji department. Book Appointment →

What is Hodgkin Lymphoma — Nodular Sclerosing Type?

Nodular sclerosing classical Hodgkin lymphoma (NS-cHL) accounts for 60-80% of classical Hodgkin lymphoma cases. It typically presents in adolescents and young adults (peak 15-35 years) with anterior mediastinal involvement and may extend to cervical and supraclavicular lymph nodes. Histopathology shows nodules of mixed inflammatory cells separated by collagen bands, with characteristic lacunar Reed-Sternberg cells.

Reed-Sternberg cells are derived from germinal center B cells and express CD15 and CD30 but lack typical B-cell markers. NF-kB pathway activation, JAK/STAT signaling, and immune evasion via PD-L1/L2 are key biological hallmarks, opening avenues for targeted therapy including brentuximab vedotin (anti-CD30) and PD-1 inhibitors (nivolumab, pembrolizumab).

Treatment is risk-adapted using stage (Ann Arbor/Lugano), bulk, and prognostic scores. Early-stage favorable disease responds to ABVD chemotherapy with or without involved-site radiotherapy. Advanced-stage disease is treated with ABVD, escalated BEACOPP, or A+AVD (brentuximab + AVD). Interim FDG-PET response guides therapy intensification or de-escalation. Five-year survival exceeds 90% for early-stage and 75-85% for advanced disease.

Symptoms

Painless cervical or supraclavicular lymphadenopathy
Anterior mediastinal mass on imaging
B symptoms: fever, drenching night sweats, weight loss >10%
Pruritus (sometimes severe)
Alcohol-induced lymph node pain
Cough or dyspnea (mediastinal mass)
Splenomegaly (less common)
Fatigue and reduced exercise tolerance

Risk Factors

Adolescence and young adulthood (15-35 years peak)
Female predominance in NS subtype
Epstein-Barr virus association (lower in NS than other subtypes)
HIV infection
Immunosuppression after transplant
Family history of Hodgkin or non-Hodgkin lymphoma
Higher socioeconomic status (NS-cHL incidence)
Autoimmune conditions

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Persistent painless lymphadenopathy >2-4 weeks
  • Mediastinal mass on chest X-ray or CT
  • Unexplained fever, night sweats, or weight loss
  • Severe pruritus without dermatologic cause
  • Alcohol-induced node pain
  • Pediatric or young adult with constitutional symptoms

Treatment Methods

01
Early favorable: ABVD ± involved-site radiotherapy
02
Early unfavorable: ABVD with consolidation radiotherapy
03
Advanced disease: ABVD, escalated BEACOPP, or A+AVD
04
Interim PET-guided therapy adaptation
05
Brentuximab vedotin for CD30+ relapsed/refractory disease
06
PD-1 inhibitors (nivolumab, pembrolizumab) for refractory cases
07
Autologous stem cell transplant for chemo-sensitive relapse
08
Allogeneic transplant or CAR-T trials for selected refractory cases

Which Department to Visit?

You can visit our Hematoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Hematoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Anaemia

Dahiliye (İç Hastalıkları)

Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.

Iron Deficiency Anaemia

Dahiliye (İç Hastalıkları)

Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.

Vitamin B12 Deficiency

Dahiliye (İç Hastalıkları)

Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.

Hypertension (High Blood Pressure) Management

Dahiliye (İç Hastalıkları)

Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.

Chronic Kidney Disease

Dahiliye (İç Hastalıkları)

Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.

Hepatitis B (HBV)

Dahiliye (İç Hastalıkları)

Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.

Hepatitis C (HCV)

Dahiliye (İç Hastalıkları)

Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.

Fatty Liver Disease

Dahiliye (İç Hastalıkları)

Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity and metabolic syndrome and is largely reversible with early treatment.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.